Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC

Clinical trial NCT07547332 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07547332
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Start date: 2026-04-06
Primary completion: 2028-01-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.